IPO Window Opens, but Liquidity Faces a Supply Test

The thesis

The U.S. equity financing window is open, but the signal is mixed: issuance is broad enough to test the market’s absorption capacity, while strong operating demand remains concentrated in selected growth and consumer companies. The key question is no longer whether companies can raise capital; it is whether primary issuance, secondary supply, lockup releases and buybacks can coexist without making liquidity more fragile.

That distinction matters for the FN2 scope—DDOG, SNOW, RH, WSM, ETH, LZB, LESL and TPX—even though none of those names is itself the central IPO event in this article. Their earnings trajectories are a useful demand-side test. If corporate spending and consumer demand remain resilient, new supply may be absorbed. If guidance becomes more dependent on price, promotions or a narrow AI cohort, the same issuance backdrop can expose volatility beneath the headline index strength.

A reopening with a supply test

Renaissance Capital’s September 24 review says third-quarter 2026 activity reached 31 U.S. listings and $34.9 billion of proceeds, while concerns about AI spending and higher bond yields weighed on the expected fall pickup.^[1] A separate market tally reports 239 U.S. IPOs through September 18, five-year-over-year percent below the comparable 2025 pace.^[1] The precise counts differ by methodology, but the direction is clear: the market is active, and the composition of proceeds matters more than a simple deal-count headline.

The first-half backdrop was unusually strong. Houlihan Lokey’s Q2 equity-capital-markets update reported $297.1 billion of U.S.-focused proceeds in the first half, with IPO deal count nearly doubling year over year.^[2] That creates a two-sided interpretation:

• Constructive: functioning primary markets give growth companies access to capital, employees greater liquidity and private investors an exit route.
• Cautionary: a wave of large transactions can become a supply shock if demand is concentrated in a small number of fashionable themes or if rates rise while the calendar accelerates.

The September stumble is therefore informative. A healthy market does not need every proposed deal to clear at maximum size or valuation; it needs issuers to adjust size, price and timing without disorderly after-effects.

Why lockups and secondaries are the plumbing

An IPO is only the first release of equity supply. Lockup expirations, staged unlocks, follow-on offerings and shareholder secondaries determine when additional shares become available. The practical risk is not that every unlocked holder sells. It is that investors begin pricing the possibility of selling before the supply arrives, widening spreads or increasing volatility around the event.

Recent examples show why calendars need to be read at the share level, not just the company level. Reporting on Cerebras described staged releases of 14.6 million shares at a time, rather than one single unlock date.^[3] Reporting on SpaceX identified another 319 million shares becoming eligible on September 24.^[3] Those are company-specific facts, not a template for every IPO, but they illustrate the market-structure issue: the timing and concentration of potential supply can matter as much as the original offering.

A useful checklist for any new listing or secondary is:

The demand test: earnings still set the tone

The operating evidence in the tracked names is strongest at DDOG. Datadog reported Q2 2026 revenue of $1.12 billion, up 36% year over year, with high-20s growth excluding AI customers, broad strength across customer sizes and industries, and 4,720 customers above $100,000 of annual recurring revenue.^[1][4] Management also described AI-native customers as a rapidly growing and diversifying group. That is supportive of risk appetite, but it also contains a concentration warning: investors should distinguish broad software demand from demand tied to a narrower AI cohort.

RH provides the counterweight. In its Q1 fiscal 2026 call, the company reported revenue of $800.3 million and raised its fiscal-year outlook, but also disclosed meaningful pre-opening and startup costs tied to international expansion.^[5] In the Q2 call, management framed demand around design, quality and perceived value rather than price alone.^[5] That is a viable brand strategy, but it is not the same evidence as broad, low-friction consumer demand.

For SNOW, WSM, ETH, LZB, LESL and TPX, this pass does not establish a uniform, current earnings signal strong enough to treat them as one basket. That is itself useful. A market-structure thesis should not smuggle in unsupported fundamental conclusions. The evidence supports a selective demand backdrop, not a blanket claim that all eight will compound earnings over the next year.

At 12:45 ET on September 24, the delayed FMP snapshot showed DDOG at $256.27, up 1.90%, SNOW at $334.53, down 0.08%, RH at $122.77, down 1.46%, WSM at $228.24, up 0.18%, LZB at $29.63, down 1.27%, LESL at $0.42, up 0.36%, and TPX at $65.81, up 1.04%; the TPX observation was stale, dated February 26, 2025, and should not be treated as a current price.^[6] The snapshot was 15 minutes delayed, so it is context rather than a trading signal.

Market rules are changing at the margin

The SEC proposed amendments in 2026 addressing trade-through rules and locked and crossed markets under Regulation NMS.^[7] Separately, the Commission approved a temporary amendment to the Limit Up-Limit Down plan establishing price-band protections in overnight trading.^[7] These developments matter because liquidity is not just a volume statistic. It is also the rules governing where orders can interact, how protected quotes work and how extreme moves are interrupted.

Rule changes can improve resilience, but they can also shift execution costs among venues and participants. The correct early-warning indicators are therefore operational: quote depth, spreads, auction imbalances, halts, off-exchange volume and the behavior of stocks immediately after a lockup or secondary event. A calm index can coexist with poor liquidity in individual new issues.

Buybacks versus issuance

Buybacks are the natural counterweight to equity supply, but an authorization is not a completed purchase. Public reporting cited estimates of approximately $960 billion in announced buybacks alongside roughly $700 billion of U.S. equity issuance in 2026, including IPOs, secondaries, convertibles and SPACs. Those figures should be treated as reported estimates, and they are not directly comparable without aligning dates, completion rates and instrument definitions.

The better framework is to track realized flows:

1. Primary shares issued and net proceeds raised.
2. Secondary shares released by insiders, sponsors or early investors.
3. Shares actually repurchased, not merely authorized.
4. ETF and mutual-fund flows that may absorb or amplify new supply.
5. Volatility and spreads around pricing, listing, lockup and earnings dates.

If buybacks are executed steadily while earnings broaden, supply can be absorbed. If issuance rises while repurchases remain mostly prospective and demand narrows to a few themes, the market can look liquid until a catalyst forces simultaneous selling.

What to watch next

• The fall IPO calendar: Watch whether issuers proceed, resize or postpone as rates and AI-spending concerns compete with strong fundraising demand.
• Post-listing price discovery: Measure first-week dispersion, turnover and spread behavior rather than relying on the first-day return.
• Lockup clusters: Identify staged unlocks and large shareholder positions before treating an expiration as a binary event.
• Secondary-versus-primary mix: A high secondary share can increase float without adding corporate investment capacity.
• Buyback completion: Look for repurchase execution in filings, not only authorization headlines.
• DDOG’s breadth: Continued growth outside AI-native customers would support the idea that demand can absorb more equity supply; renewed optimization or customer concentration would weaken it.^[4]
• Consumer elasticity at RH and peers: Watch whether demand survives pricing and whether margin recovery arrives without relying on unusually favorable execution.^[5]
• Market-structure implementation: Track SEC and exchange actions on tick sizes, access fees, locked and crossed markets, overnight bands and auction mechanics.^[7]

Bottom line

The evidence supports a cautiously constructive but conditional view. The IPO window is open and operating demand is healthy in parts of the market, especially software tied to cloud and AI adoption. But the next test is absorption: whether primary issuance, secondaries and lockup releases can be met by broad demand and completed buybacks without a deterioration in spreads, depth and volatility.

For the FN2 scope, that means separating the evidence. DDOG currently offers the clearest operating confirmation; RH shows that demand can coexist with execution and margin risks; the remaining names require company-specific updates before they can be used to validate a broad earnings-resilience claim. The market’s plumbing—not the headline IPO count—will tell us whether the reopening is durable.